RF - Recent Approval of Baricitinib for Alopecia Areata: Safety and Efficacy Data

被引:0
|
作者
Corbella-Bagot, L. [1 ]
Luque-Luna, M. [1 ]
Morgado-Carrasco, D. [1 ,2 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain
[2] Hosp Figueras, Dept Dermatol, Figueras, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2023年 / 114卷 / 08期
关键词
Baricitinib; Alopecia areata; JAK inhibitors; Trichology;
D O I
10.1016/j.ad.2022.10.051
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:T718 / T719
页数:2
相关论文
共 50 条
  • [41] BARICITINIB IN ALOPECIA AREATA: A BUDGET IMPACT ANALYSIS IN SAUDI SETTING
    Alshahrani, A.
    Al-Aqeel, S.
    Alhawashi, S. T.
    Al-Nasser, M. S.
    Zaitoun, M.
    VALUE IN HEALTH, 2024, 27 (06) : S78 - S78
  • [42] Atopic dermatitis and multilocular alopecia areata simultaneously treated with baricitinib
    Pestana, M.
    Caldeira, M. Brito
    Duarte, B.
    ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (02): : 200 - 201
  • [43] Successful treatment of alopecia areata-associated trachyonychia with baricitinib
    Rozsa, Petra
    Degovics, Doeniz
    Baltas, Eszter
    Gyulai, Rolland
    Kemeny, Lajos
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (08) : 1089 - 1090
  • [45] Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation
    Diluvio, L.
    Matteini, E.
    Lambiase, S.
    Cioni, A.
    Gaeta Shumak, R.
    Dattola, A.
    Bianchi, L.
    Campione, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : e478 - e480
  • [46] Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
    King, Brett
    Mostaghimi, Arash
    Shimomura, Yutaka
    Zlotogorski, Abraham
    Choi, Gwang-Seong
    Blume-Peytavi, Ulrike
    Passeron, Thierry
    Holzwarth, Katrin
    Dutronc, Yves
    McCollam, Jill
    Yang, Fan Emily
    Stanley, Sarah
    Wu, Wen-Shuo
    Sinclair, Rodney
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (02) : 218 - 227
  • [47] Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
    King, B.
    Mostaghimi, A.
    Shimomura, Y.
    Zlotogorski, A.
    Holzwarth, K.
    Issa, M.
    Dutronc, Y.
    Stanley, S.
    Wu, W. -S.
    Sinclair, R.
    Fotiou, K.
    ALLERGOLOGIE, 2022, 45 (08) : 607 - 607
  • [48] Integrated safety analysis of baricitinib in adults with severe alopecia areata from 2 randomized clinical trials
    King, Brett
    Mostaghimi, Arash
    Shimomura, Yutaka
    Zlotogorski, Abraham
    Holzwarth, Katrin
    Issa, Maher
    Dutronc, Yves
    Stanley, Sarah
    Wu, Wen-Shuo
    Sinclair, Rodney
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB176 - AB176
  • [49] Safety and efficacy results of a clinical study of efalizumab in patients with alopecia areata
    Price, V.
    Hordinsky, M.
    Leonardi, C.
    Roberts, J.
    Olsen, E.
    Rafal, E.
    Korman, N.
    Leung, H.
    Garovoy, M.
    Caro, I.
    Whiting, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 105 - 105
  • [50] Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
    Crispin, Milene Kennedy
    Ko, Justin M.
    Craiglow, Brittany G.
    Li, Shufeng
    Shankar, Gautam
    Urban, Jennifer R.
    Chen, James C.
    Cerise, Jane E.
    Jabbari, Ali
    Winge, Marten C. G.
    Marinkovich, M. Peter
    Christiano, Angela M.
    Oro, Anthony E.
    King, Brett A.
    JCI INSIGHT, 2016, 1 (15):